Previous 10 | Next 10 |
BATON ROUGE, La., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, announced today that Ivanetta Davis Samuels is joining its Board of Directors, effective December 15, 2020. “I am excited to wel...
BATON ROUGE, La., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Jefferies Virtual London Healthcare ...
BATON ROUGE, La., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Stephens Annual Investment Con...
BATON ROUGE, La., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 29 th Annual Credit Suisse Virtu...
As COVID brought healthcare stocks back to the spotlight, it will be future healthcare stocks that will bring the largest gains. Here are four that are poised to benefit from an aging population: Seattle Genetics, Inc. (SGEN), Amedisys Inc. (AMED), LHC Group (LHCG), and Masimo Corporation (MA...
The following slide deck was published by Amedisys, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Amedisys, Inc. 2020 Q3 - Results - Earnings Call Presentation
Amedisys, Inc. (AMED) Q3 2020 Results Conference Call October 29, 2020 11:00 AM ET Company Participants Nick Muscato - Senior Vice President of Finance Paul Kusserow - Chairman, CEO and President Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer Dave Kemmerly - Chief...
Image source: The Motley Fool. AMEDISYS Inc (NASDAQ: AMED) Q3 2020 Earnings Call Oct 29, 2020 , 11:00 a.m. ET Operator Continue reading For further details see: AMEDISYS Inc (AMED) Q3 2020 Earnings Call Transcript
Amedisys, Inc. (AMED) Q3 2020 Earnings Conference Call October 29, 2020 10:50 A.M. ET Company Participants Nick Muscato - Vice President of Strategic Finance Paul Kusserow - Chairman, President and Chief Executive Officer Scott Ginn - Chief Financial Officer Christopher Gerard - Chief Operati...
Amedisys (AMED): Q3 Non-GAAP EPS of $2.24 beats by $0.97; GAAP EPS of $2.16 beats by $0.92.Revenue of $544.07M (+10.0% Y/Y) beats by $11.14M.Press Release For further details see: Amedisys EPS beats by $0.97, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...